Current research advancements in neurogenic inflammation and pain-related disorders, including migraine and arthritic conditions, have established calcitonin gene-related peptide (CGRP) as a crucial neuromodulator in pain pathophysiology. The gene discussed is CALCA; the disease is migraine disorder.